Long-term safety studies: insights into requirements for changing cyclosporine formulations.
D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003625:Data Collection; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D017410:Practice Guidelines as Topic; D012449:Safety; D014181:Transplantation Immunology; D016896:Treatment Outcome; D006113:United Kingdom